Goldman Sachs Group Inc Gossamer Bio, Inc. Transaction History

Goldman Sachs Group Inc

$596 Billion
Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 939,603 shares of GOSS stock, worth $986,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares

939,603

Previous 114,556 720.21%

Holding current value

$986,583

Previous $103,000 902.91%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$0.85 - $1.53 $701,289 - $1.26 Million	825,047 Added 720.21%	939,603 $1.03 Million
Q4 2024 Feb 11, 2025	SELL	$0.66 - $1.07 $406,690 - $659,331	-616,198 Reduced 84.32%	114,556 $103,000
Q3 2024 Nov 14, 2024	SELL	$0.79 - $1.25 $1.1 Million - $1.73 Million	-1,386,960 Reduced 65.49%	730,754 $723,000
Q2 2024 Aug 13, 2024	SELL	$0.51 - $1.27 $293,888 - $731,838	-576,251 Reduced 21.39%	2,117,714 $1.91 Million
Q1 2024 May 15, 2024	SELL	$0.8 - $1.51 $25,828 - $48,751	-32,286 Reduced 1.18%	2,693,965 $3.18 Million
Q4 2023 Feb 13, 2024	BUY	$0.48 - $1.08 $509,639 - $1.15 Million	1,061,749 Added 63.79%	2,726,251 $2.48 Million
Q3 2023 May 14, 2024	SELL	$0.78 - $1.82 $828,164 - $1.93 Million	-1,061,749 Reduced 38.95%	1,664,502 $1.38 Million
Q3 2023 Nov 14, 2023	BUY	$0.78 - $1.82 $983,295 - $2.29 Million	1,260,635 Added 312.14%	1,664,502 $1.38 Million
Q2 2023 May 14, 2024	SELL	$0.98 - $1.53 $909,395 - $1.42 Million	-927,955 Reduced 69.68%	403,867 $484,000
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $909,395 - $1.42 Million	-927,955 Reduced 69.68%	403,867 $484,000
Q1 2023 May 14, 2024	SELL	$0.96 - $2.92 $419,515 - $1.28 Million	-436,995 Reduced 24.71%	1,331,822 $1.68 Million
Q1 2023 May 11, 2023	SELL	$0.96 - $2.92 $419,515 - $1.28 Million	-436,995 Reduced 24.71%	1,331,822 $1.68 Million
Q4 2022 May 14, 2024	BUY	$1.74 - $12.87 $1.25 Million - $9.23 Million	717,305 Added 68.22%	1,768,817 $3.84 Million
Q4 2022 Feb 13, 2023	BUY	$1.74 - $12.87 $1.25 Million - $9.23 Million	717,305 Added 68.22%	1,768,817 $3.84 Million
Q3 2022 May 14, 2024	BUY	$7.21 - $14.88 $2.96 Million - $6.11 Million	410,923 Added 64.15%	1,051,512 $12.6 Million
Q3 2022 Nov 10, 2022	BUY	$7.21 - $14.88 $2.96 Million - $6.11 Million	410,923 Added 64.15%	1,051,512 $12.6 Million
Q2 2022 May 14, 2024	SELL	$5.97 - $9.97 $12.5 Million - $20.8 Million	-2,085,662 Reduced 76.5%	640,589 $5.36 Million
Q2 2022 Aug 15, 2022	BUY	$5.97 - $9.97 $1.1 Million - $1.84 Million	184,697 Added 40.51%	640,589 $5.36 Million
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $1.79 Million - $2.65 Million	211,804 Added 86.77%	455,892 $3.96 Million
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $3.32 Million - $4.61 Million	-327,829 Reduced 57.32%	244,088 $2.76 Million
Q3 2021 Nov 10, 2021	BUY	$7.25 - $13.23 $4.15 Million - $7.57 Million	571,917 New	571,917 $7.19 Million

Others Institutions Holding GOSS

# of Institutions

122

Shares Held

160M

Call Options Held

2.11M

Put Options Held

57.8K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $98.7M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Gossamer Bio, Inc. Transaction History